Status:
COMPLETED
A Study of the Effects of Single Dose Corticosteroids on Response to Allergens
Lead Sponsor:
Merck Sharp & Dohme LLC
Conditions:
Allergic Rhinitis
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
This study will investigate whether changes in inflammatory mediators produced by the nose after exposure to an allergen can be used to evaluate the anti-inflammatory effects of novel drugs for the tr...
Eligibility Criteria
Inclusion
- Patient is allergic to Timothy grass pollen
- Female patients have a negative pregnancy test and agree to use birth control throughout the study
- Male patients agree to use birth control throughout the study
- Patient has been a nonsmoker for at least 6 months
- Patient agrees to avoid the use of aspirin and other Non-steroidal anti-inflammatory drugs (NSAIDs) throughout study
Exclusion
- Patient is breastfeeding
- Patient has any respiratory disease other than mild stable asthma that does not require treatment
- Patient consumes more than 3 alcoholic beverages per day
- Patient consumes more than 6 caffeinated beverages per day
- Patient has had major surgery or has donated or lost 1 unit of blood within 4 weeks of screening
- Patient has severe allergies
Key Trial Info
Start Date :
February 4 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 21 2009
Estimated Enrollment :
19 Patients enrolled
Trial Details
Trial ID
NCT00828061
Start Date
February 4 2009
End Date
May 21 2009
Last Update
April 2 2019
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.